Application of a free radical scavenger edaravone in patients with hemorrhagic stroke


BACKGROUND. The free radical scavenger edaravone helps to reduce the area of ischemic injury and improve the longterm effects of stroke, and is therefore widely used in the treatment of ischemic stroke. However, the role of edaravone in the treatment of hemorrhagic stroke patients has not yet been clarified.

OBJECTIVE. To investigate the feasibility and effectiveness of the use of the free radical scavenger edaravone in the treatment of patients with acute hemorrhagic stroke.

MATERIALS AND METHODS. A search was conducted for studies and systematic reviews for the keywords “acute stroke”, “intracerebral hemorrhage”, “subarachnoid hemorrhage”, “hemorrhagic transformation”, “edaravone” in the Google Scholar database published between 2003 and 2020.

RESULTS. The use of edaravone in patients with intracerebral hemorrhage was accompanied by activation of anti-inflammatory and reduction of pro-inflammatory peptides, activation of anti-apoptotic mechanisms, reduction of lipid peroxidation and oxidative trauma, reduction of permeability of the hematocenosis.

CONCLUSIONS. The main effects of edaravone have been to reduce neurological deficits, accelerate the rate of recovery of neurological disorders, and improve functional outcomes. Thus, the introduction of edaravone in patients with hemorrhagic stroke has proven to be reliably effective and safe.

Keywords: acute stroke, intracerebral hemorrhage, subarachnoid hemorrhage, edaravone.


Khobzey N.K., Mishchenko T.S., Golik V.A., Ipatov A.V. Stroke epidemiology, clinical and expert aspects in Ukraine. Vascular diseases of the brain. 2010; 4: 2-6.

Halushko O.A. Peculiarities of occurrence and course of electrolyte disturbances in the acute period of stroke in patients with diabetes mellitus. Emergency Medicine. 2017; 1 (80): 87-92.

Fisher M. Neuroprotection of acute ischemic stroke. Where are we? Neuroscientist. 1999; 5: 392-401.

Modern principles of diagnosis and treatment of patients with acute ischemic stroke and TIA (adapted clinical guidelines). – K.: Publisher D.V. Guliaev, 2012. – 144 p.

Moretti A., Ferrari F., Villa R. Neuroprotection for ischaemic stroke: current status and challenges. Pharmacol. Ther. 2015 Feb; 146: 23-34.

Kern R., Nagayama M., Toyoda K., Steiner T., Hennerici M., Shinohara Y. Comparison of the European and Japanese guidelines for the management of ischemic stroke. Cerebrovasc. Dis. 2013; 35 (5): 402-8.

Watanabe K., Tanaka M., Yuki S., Hirai M., Yamamoto Y. How effective is edaravone in the treatment of acute ischemic stroke and amyotrophic lateral sclerosis? International Journal of Neurology. 2018; 6 (100): 46-58.

In Ukraine, the emergence of a new drug Xavron (edaravone) for the treatment of acute ischemic stroke and amyotrophic lateral sclerosis. Weekly PHARMACY. 2018; 31 (1152): 2.

Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc. Dis. 2003; 15 (3): 222-9.

Kaste M., Murayama S., Ford G., Dippel D., Walters M., Tatlisumak T. Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen. Cerebrovasc. Dis. 2013; 36: 196-204.

Ohta Y., Takamatsu K., Fukushima T., Ikegami S., Takeda I., Ota T. et al. Efficacy of the free radical scavenger, edaravone, for motor palsy of acute lacunar infarction. Intern. Med. 2009; 48: 593-6.

Feng S., Yang Q., Liu M., Li W., Yuan W., Zhang S., Wu B., Li J. Edaravone for acute ischaemic stroke. Cochrane Database Syst. Rev. 2011; 12: CD007230. doi: 10.1002/14651858.CD007230.pub2.

Kimura K., Aoki J., Sakamoto Y., Kobayashi K., Sakai K., Inoue T. et al. Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients a preliminary study. J. Neurol. Sci. 2012. 313: 132-6.

Yang J., Liu M., Zhou J., Zhang S., Lin S., Zhao H. Edaravone for acute intracerebral haemorrhage. Cochrane Database Syst. Rev. 2011 Feb 16; 2: CD007755. doi: 10.1002/14651858.CD007755.pub2.

Chen Z., Zhang J., Chen Q., Guo J., Zhu G., Feng H. Neuroprotective effects of edaravone after intraventricular hemorrhage in rats. Neuroreport. 2014 Jun 18; 25 (9): 635-40. doi: 10.1097/WNR.0000000000000050.

Miao H., Jiang Y., Geng J., Zhang B., Zhu G., Tang J. Edaravone administration confers neuroprotection after experimental intracerebral hemorrhage in rats via NLRP3 suppression. J. Stroke Cerebrovasc. Dis. 2020 Jan; 29 (1): 104468. doi: 10.1016/j.jstrokecerebrovasdis.2019.104468.

Nakamura T., Kuroda Y., Yamashita S., Zhang X., Miyamoto O., Tamiya T., Nagao S., Xi G., Keep R., Itano T. Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke. 2008 Feb; 39 (2): 463-9. DOI: 10.1161/STROKEAHA.107.486654.

Shang H., Cui D., Yang D., Liang S., Zhang W., Zhao W. The radical scavenger edaravone improves neurologic function and perihematomal glucose metabolism after acute intracerebral hemorrhage. J. Stroke Cerebrovasc. Dis. 2015 Jan; 24 (1): 215-22. doi: 10.1016/j.jstrokecerebrovasdis.2014.08.021.

Yang J., Cui X., Li J., Zhang C., Zhang J., Liu M. Edaravone for acute stroke: meta-analyses of data from randomized controlled trials. Dev. Neurorehabil. 2015; 18 (5): 330-5. doi: 10.3109/17518423.2013.830153.

Zhang Y., Yang Y., Zhang G., Gao M., Ge G., Wang Q. et al. Stereotactic administration of edaravone ameliorates collagenase-induced intracerebral hemorrhage in rat. CNS Neurosci. Ther. 2016 Oct; 22 (10): 824-35. doi: 10.1111/cns.12584.

Zhao F., Liu Z. Beneficial effects of edaravone on the expression of serum matrix metalloproteinase-9 after cerebral hemorrhage. Neurosciences (Riyadh). 2014 Apr; 19 (2): 106-10.

Zhou F., Chen G., Zhang J. Edaravone reduces brain oedema and attenuates cell death after intracerebral haemorrhage in mice. Brain Inj. 2009 Apr; 23 (4): 353-7. doi: 10.1080/02699050902788527.

Zhu Y., Liu C., Sun Z. Early combined therapy with pharmacologically induced hypothermia and edaravone exerts neuroprotective effects in a rat model of intracerebral hemorrhage. Cell Biochem. Biophys. 2015 Nov; 73 (2): 581-7. doi: 10.1007/s12013-015-0584-x.

Zheng M., Wang X., Yang J., Ma S., Wei Y., Liu S. Changes of complement and oxidative stress parameters in patients with acute cerebral infarction or cerebral hemorrhage and the clinical significance. Exp. Ther. Med. 2020 Jan; 19 (1): 703-9. doi: 10.3892/etm.2019.8229.

Hasegawa S., Hasegawa Y., Miura M. Current therapeutic drugs against cerebral vasospasm after subarachnoid hemorrhage: a comprehensive review of basic and clinical studies. Curr. Drug Deliv. 2017 Sep 6; 14 (6): 843-52. doi: 10.2174/1567201813666160808100937.

Munakata A., Ohkuma H., Nakano T., Shimamura N., Asano K., Naraoka M. Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2009 Mar; 64 (3): 423-8; discussion 428-9. doi: 10.1227/01.NEU.0000338067.83059.EB.

Munakata A., Ohkuma H., Shimamura N. Effect of a free radical scavenger, edaravone, on free radical reactions: related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model. Acta Neurochir. Suppl. 2011; 110 (Pt. 2): 17-22. doi: 10.1007/978-3-7091-0356-2_4.

Nakagomi T., Yamakawa K., Sasaki T., Saito I., Takakura K. Effect of edaravone on cerebral vasospasm following experimental subarachnoid hemorrhage. J. Stroke Cerebrovasc. Dis. 2003 Jan; 12 (1): 17-21.

Fumoto T., Naraoka M., Katagai T., Li Y., Shimamura N., Ohkuma H. The role of oxidative stress in microvascular disturbances after experimental subarachnoid hemorrhage. Transl. Stroke Res. 2019 Dec; 10 (6): 684-694. doi: 10.1007/s12975-018-0685-0.

Cai Z., Zhang H., Song H., Piao Y., Zhang X. Edaravone combined with cinepazide maleate on neurocyte autophagy and neurological function in rats with subarachnoid hemorrhage. Exp. Ther. Med. 2020 Jan; 19 (1): 646-50. doi: 10.3892/etm.2019.8240.

Okamura K., Tsubokawa T., Johshita H., Miyazaki H., Shiokawa Y. Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia. Neurol. Res. 2014 Jan; 36 (1): 65-9. doi: 10.1179/1743132813Y.0000000259.

Yagi K., Kitazato K., Uno M., Tada Y., Kinouchi T., Shimada K., Nagahiro S. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator. Stroke. 2009 Feb; 40 (2): 626-31. doi: 10.1161/STROKEAHA.108.520262.

Zheng J., Chen X. Edaravone offers neuroprotection for acute diabetic stroke patients. Ir. J. Med. Sci. 2016 Nov; 185 (4): 819-24. DOI: 10.1007/s11845-015-1371-9.

Yamaguchi T., Awano H., Matsuda H., Tanahashi N.; PROTECT 4.5 Investigators. Edaravone with and without .6 Mg/Kg alteplase within 4.5 hours after ischemic stroke: a prospective cohort study (PROTECT 4.5). J. Stroke Cerebrovasc. Dis. 2017 Apr; 26 (4): 756-65. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.011.

Kono S., Deguchi K., Morimoto N., Kurata T., Yamashita T., Ikeda Y. et al. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age. J. Stroke Cerebrovasc. Dis. 2013 Oct; 22 (7): 1175-83. doi: 10.1016/j.jstrokecerebrovasdis.2013.02.010.

Mishina M., Komaba Y., Kobayashi S., Kominami S., Fukuchi T., Mizunari T., Teramoto A., Katayama Y. Administration of free radical scavenger edaravone associated with higher frequency of hemorrhagic transformation in patients with cardiogenic embolism. Neurol. Med. Chir. (Tokyo). 2008 Jul; 48 (7): 292-7.

Powers W., Rabinstein A., Ackerson T., Adeoye O., Bambakidis N., Becker K. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 Guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association / American Stroke Association. Stroke. 2019 Dec; 50 (12): e344-e418. doi: 10.1161/STR.0000000000000211.

How to Cite
Halushko, O. (2021). Application of a free radical scavenger edaravone in patients with hemorrhagic stroke. Infusion & Chemotherapy, (1), 28-36.

Author Biography

O.A. Halushko, PL Shupyk named National Healthcare University of Ukraine, Kyiv, Ukraine

Halushko Oleksandr Anatoliiovych
Department of Anesthesiology and Intensive Therapy
MD, professor.
9, Dorogozhytska st., Kyiv, 04112, Ukraine.